|
CA3093876A1
|
|
Method of detecting and/or predicting seizures
|
|
US2018154016A1
|
|
DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
|
|
US2018153761A1
|
|
Non-surgical torso deformity correction devices and methods related thereto
|
|
AU2017261283A1
|
|
Rapid extraction of nucleic acids from clinical samples for downstream applications
|
|
EP3376955A1
|
|
Cord collection clamp
|
|
US2017183384A1
|
|
Factor H binding protein variants and methods of use thereof
|
|
HK1190343A1
|
|
Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis gna1870
|
|
US2015205919A1
|
|
Method and system to provide patient information and facilitate care of a patient
|
|
AU2009288095A1
|
|
Peptides presenting an epitope of a domain of factor H binding protein and methods of use
|
|
AU2009288242A1
|
|
Complement factor H-based assays for serum bactericidal activity against Neisseria meningitidis
|
|
AU2009223613A1
|
|
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
|
AU2008272792A1
|
|
Oligosialic acid derivatives, methods of manufacture, and immunological uses
|
|
AU2008272785A1
|
|
Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
|
|
AU2008272854A1
|
|
Inhibitors of polysialic acid de-N-acetylase and methods for using the same
|
|
AU2008266984A1
|
|
Method of isolating stem and progenitor cells from placenta
|
|
EP2131679A1
|
|
Fatty acid formulations and methods of use thereof
|
|
AU2004283078A1
|
|
Lipophilic drug delivery vehicle and methods of use thereof
|
|
AU2004212944A1
|
|
Lipophilic drug delivery vehicle and methods of use thereof
|
